Skip to content

Guide

Setting Up a Diagnostic Laboratory or Medical-Testing Business in the UAE

Published

The short answer

A diagnostic laboratory is licensed by the health regulator for the emirate where it will operate: the Dubai Health Authority (DHA) in Dubai, the Department of Health (DOH) in Abu Dhabi, or the Ministry of Health and Prevention (MOHAP) in the other five emirates. Each regulator issues a health facility licence to the laboratory itself, on top of the commercial trade licence a Department of Economic Development or free-zone authority issues, and a separate professional licence to the laboratory director and testing staff named on the file. The detail that most often decides the setup route is whether the facility will perform and validate tests on its own premises or only collect and forward specimens to a laboratory licensed elsewhere; the two models sit under different facility classifications and different staffing requirements.

Who licenses the laboratory, and where

The regulator is set by geography, not by where the parent company registers. A laboratory operating in Dubai, including inside a Dubai free zone, is licensed by the Dubai Health Authority. One in Abu Dhabi is licensed by the Department of Health. In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the Ministry of Health and Prevention is the licensing authority, with Emirates Health Services running the public health facilities in those emirates. A founder planning a network across more than one emirate is planning more than one licensing relationship, each with its own application, its own facility inspection and its own renewal date.

A standard commercial trade licence from a Department of Economic Development or free-zone authority does not substitute for this health facility licence, and the two are sequenced: the health regulator's approval normally has to be in place before the commercial licence that lets the laboratory invoice as a business is issued. Choosing a jurisdiction before confirming which health regulator will approve the facility risks a trade licence the laboratory cannot yet use.

What the regulator checks before it licenses the facility

Each regulator licenses the laboratory as a facility, separately from the people who work in it. The laboratory director and the technical staff who perform, validate and sign off on tests need their own professional licence from the same regulator, assessed against their qualifications and experience, before the facility can open; a laboratory cannot operate on a facility licence alone while results are issued under an unlicensed name. The regulator also assesses the premises, equipment and quality-control arrangements the laboratory proposes to run, which is why a facility layout and equipment list are typically requested before fit-out begins rather than after.

This split between facility approval and professional licensing is the reason a laboratory cannot be treated as one filing. Business plans and documentation that set out the test menu, equipment list and staffing plan in the terms the regulator uses make the difference between a file that moves and one that is returned for clarification.

How money moves: banking and commercial readiness

A laboratory's income runs through more channels than a typical trading company: patient self-pay, insurer and third-party-administrator claims, and referral fees from clinics or hospitals that send it samples. A bank assessing a corporate account application for a laboratory will want to see the health facility licence, the professional licence of the laboratory director, and a credible description of which of these payment channels the business expects to use, because insurer-funded receivables behave differently from cash takings. Corporate bank account readiness work for this sector starts from that payment mix, not from the trade licence alone.

Where a laboratory is part of a group that also runs clinics or holds assets overseas, the intercompany arrangements between them (who owns the equipment, who bills the patient, who carries the liability for a result) need documenting on their own terms rather than left as an informal group understanding.

Ownership, substance and the roles the licence requires

The named laboratory director is the role a regulator checks most closely, because that person's professional licence is what allows the facility to issue results relied on for patient care. Whether one director can be named across more than one site is set by the regulator rather than assumed: the Dubai Health Authority, for example, allows a medical/clinical director to be appointed across multiple facilities that sit within the same registered group, and the Ministry of Health and Prevention allows a technical director to manage more than one private facility under conditions the authority sets, so a group planning a second site needs the regulator's specific approval for that arrangement rather than treating either outcome as the default. Technical staff performing and validating tests sit under the same professional-licensing requirement, scaled to the test menu the facility is approved for.

Ownership of the UAE entity is a separate question from these professional roles, and should be confirmed against the specific activity and emirate with the licensing authority rather than assumed from a general foreign-ownership rule. Where ownership runs through holding layers, funds or an overseas parent, that chain needs documenting for the health regulator as well as the bank, and the regulated and complex ownership setup route is built for exactly that file.

What commonly goes wrong in laboratory setups

  • Marketing a test before its clinical and regulatory status with the facility's regulator is confirmed.
  • Using a method validated for research only to support a patient-facing clinical decision.
  • Losing specimen identity or chain of custody between collection, transport and testing.
  • Letting non-clinical staff amend or release a result once it has been validated.
  • Opening a second site on the assumption that a shared director is either automatically covered or automatically excluded, rather than confirming the specific arrangement with the regulator.
  • Signing a premises lease before the regulator has approved the proposed layout.

Each of these turns a licensing question into a patient-safety or liability problem after the facility has already opened.

From licence to operating: visas, premises and renewals

The health facility licence and the commercial trade licence renew on their own cycles, and a lapse in either can stop the laboratory operating even though the other is still current. The laboratory director's and technical staff's professional licences renew separately again, tied to their own registration with the health regulator rather than to the company's licence date. A change of premises, a change of director, or the addition of a new test category to the menu each typically needs the regulator's approval before it takes effect, not a notification after the fact.

Staff visas follow the entity's own establishment registration once the trade licence is in place, and the laboratory director's own residency is usually tied to the role rather than to a separate investor visa. Patient information handled by the laboratory falls within the UAE's general data protection framework, which treats health data as a sensitive category warranting extra safeguards around storage, transfer and access.

Office towers and the Gate building in Dubai International Financial Centre

General guidance here; the detail that matters depends on your activity and markets.

Questions

Frequently asked

Can a laboratory in the UAE only collect and refer samples, without testing them itself?
Yes, in principle. A sample-collection branch that forwards specimens to a separately licensed laboratory is a recognised model, but the collection branch still needs its own approval from the relevant health regulator, covering specimen handling, storage and chain of custody, rather than operating as an unlicensed drop-off point.
Does the same laboratory director's licence cover more than one site?
It depends on the regulator and the facilities' ownership. The Dubai Health Authority allows a medical/clinical director to be appointed across multiple facilities that are part of the same registered group, and the Ministry of Health and Prevention allows a technical director to manage more than one private facility under conditions the authority sets, so a second site is not automatically barred from sharing a director, but the specific approval still needs confirming with the regulator for the facilities involved.
What happens if a laboratory wants to add a new test to its menu after opening?
Adding a test category outside the approved menu typically needs the regulator's approval before the test is offered commercially, because the facility's licence is tied to the scope of testing it was assessed against, not to the laboratory's equipment alone.
Does a laboratory embedded inside a clinic need its own separate facility licence?
It depends on how the regulator classifies the service. Some in-clinic testing sits under the clinic's own facility licence, while laboratory-scale testing with its own director and quality system is more often licensed as a distinct facility. The classification should be confirmed with the regulator for the specific test menu and site.
Do point-of-care tests run inside a clinic count as laboratory services?
Point-of-care testing is generally assessed differently from full laboratory testing, but the boundary depends on the test, the equipment and how the result is used clinically, so it should be checked against the relevant regulator's current classification rather than assumed.

Get your UAE setup plan

A diagnostic laboratory's setup turns on which health regulator will license the facility and who will be named as its laboratory director, not on which emirate offers the cheapest trade licence. Velarozone maps the facility classification, the staffing and ownership roles the licence requires, and the banking position before anything is filed; cost is built in layers and the firm's fee is itemised in the engagement letter, and how Velarozone works sets out the approach.

Apply this to your own situation

Guides describe the general position. Send us your facts and an adviser will tell you which parts actually apply to you.

Message us on WhatsApp

Free assessment: current figures are confirmed within your adviser-reviewed route comparison. Your details are not shared with third parties.

Start with a structure assessment

In an initial consultation you receive a plain-language decision summary, a document-preparation list, and the next actions for your situation. Current figures are confirmed within your adviser-reviewed route comparison.

This guide provides general information, not legal, regulatory, tax, investment, medical or financial advice. It does not guarantee a licence, authorisation, visa, bank account, funding, tax treatment or commercial outcome.

General information drawn from the CBUAE Rulebook, including the Retail Payment Services and Card Schemes Regulation (C 15/2021), and Cabinet Resolution No. (134) of 2025 as published, not legal or tax advice. Rules and guidance change, so confirm the current text and each institution's own requirements before you submit.